Use of Marrow Scintigraphy to Confirm Compensatory Marrow Rather than Active Myeloma
نویسندگان
چکیده
We present the case of a 40-year-old male with multiple myeloma for whom bone marrow scintigraphy was utilized to help differentiate between active bony myelomatous disease versus treated lesions with compensatory marrow uptake. This case demonstrates technetium (Tc-99m) sulfur colloid imaging as an inexpensive technique to quickly distinguish between active focal bone disease and reactive marrow.
منابع مشابه
Use of Marrow Scintigraphy to Confirm Compensatory Marrow Rather than Active Myeloma
We read with much interest the article entitled “Use of marrow scintigraphy to confirm compensatory marrow rather than active myeloma” by Bartel et al. published in your esteemed journal. This article enlightens us regarding a very interesting case of false positive fluorodeoxyglucose (FDG) uptake in a follow‐up case of multiple myeloma (MM). The authors in the present case have very nicely des...
متن کاملMultiple myeloma in a patient with suspected hyperparathyroidism
Multiple myeloma (MM) is a clonal B-lymphocyte neoplasm of terminally differentiated plasma cells. Imaging modalities which allow the recognition of the effects of myeloma cells on the skeletal system have been utilized for a long time. Herein, we represent a patient with generalized osteoporosis and hypercalcemia, who was referred for parathyroid scan, in whom the widespread bone marrow techne...
متن کاملClinical significance of additional lateral imaging in diagnosis of prosthesis infection by combined Tc-99m labeled leukocyte/bone marrow scintigraphy
Introduction: Recently the most accurate diagnostic method in the diagnosis of prosthesis infection is the combination of Tc-99m labeled leukocyte/bone marrow imaging. However the diagnostic efficiency of the test is influenced because of its low spatial resolution. Recently SPECT/CT imaging is implicated in this test with efficient additional diagnostic improvement. In the dep...
متن کاملIn vitro Effect of Pomalidomide on Bone Marrow Mononuclear Cells from Multiple Myeloma Patients
Background: Many features of anticancer drugs, including cytotoxicity and/or cytokine induction, are studied using cell lines orhuman blood leukocytes. However, in a disease such as multiple myeloma, most cancerous cells are resided within bone marrowmononuclear cells. In the present study, we investigated the effect of pomalidomide on apoptosis and IL-2 production of bonemarrow mononuclear cel...
متن کاملValue of tc99m (V) dmsa compared to tc99m Mibi in Evaluation of Bone and Bone Marrow Lesions in Patients with Multiple Myeloma
Bone scintigraphy has some limitations in detecting bone lesions at the time of diagnosis since Tc99m MDP scintigraphy does not trace lesions lacking osteoblastic activity3. Tc99m Sestamibi (MIBI) has been proposed as a potential tracer in patients with multiple myeloma, as its increased uptake in the bone marrow has been reported as an indicator of myeloma activity4. It has been suggested to b...
متن کامل